Table 5.
In-hospital and postdischarge clinical adverse events.
| N (%) | PCI (n = 75) | No PCI (n = 328) | P value |
|---|---|---|---|
| In-hospital events: | |||
| Death | 0 (0) | 1 (0.3) | >0.9 |
| MI | 15 [17] | 4 (1.2) | <0.001 |
| Repeat revascularization | 14 (18.7) | 3 (0.9) | <0.001 |
| CVA | 3 (4.0) | 2 (0.6) | 0.047 |
| In-hospital MACE | 22 (29.3) | 9 (2.8) | <0.001 |
|
| |||
| Postdischarge events: | |||
| Unstable angina hospitalization | 10 (13.3) | 19 (5.8) | 0.043 |
| Death | 0 (0) | 4 (1.2) | >0.9 |
| Recurrent MI | 15 [17] | 59 (18.0) | 0.74 |
| Recurrent de novo SCAD | 5 (6.7) | 40 (12.2) | 0.22 |
| Repeat revascularization | 11 (14.7) | 10 (3.0) | <0.001 |
| CVA | 1 (1.3) | 4 (1.2) | >0.9 |
| Postdischarge MACE | 18 (24.0) | 65 (19.8) | 0.43 |
| Overall MACE | 44 (58.7) | 74 (22.6) | <0.001 |